The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Liver Fat Is Reduced by an Isoenergetic MUFA Diet in a Controlled Randomized Study in Type 2 Diabetic Patients
Open accessAbstract
OBJECTIVE: To evaluate the effects of qualitative dietary changes and the interaction with aerobic exercise training on liver fat content independent of weight loss in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: With use of a factorial 2 × 2 randomized parallel-group design, 37 men and 8 women, aged 35-70 years, with type 2 diabetes in satisfactory blood glucose control on diet or diet plus metformin treatment were assigned to one of the following groups for an 8-week period: 1) high-carbohydrate/high-fiber/low-glycemic index diet (CHO/fiber group), 2) high-MUFA diet (MUFA group), 3) high-carbohydrate/high-fiber/low-glycemic index diet plus physical activity program (CHO/fiber+Ex group), and 4) high-MUFA diet plus physical activity program (MUFA+Ex group). Before and after intervention, hepatic fat content was measured by (1)H NMR. RESULTS: Dietary compliance was optimal and body weight remained stable in all groups. Liver fat content decreased more in MUFA (-29%) and MUFA+Ex (-25%) groups than in CHO/fiber (-4%) and CHO/fiber+Ex groups (-6%). Two-way repeated-measures ANOVA, including baseline values as covariate, showed a significant effect on liver fat content for diet (P = 0.006), with no effects for exercise training (P = 0.789) or diet-exercise interaction (P = 0.712). CONCLUSIONS: An isocaloric diet enriched in MUFA compared with a diet higher in carbohydrate and fiber was associated with a clinically relevant reduction of hepatic fat content in type 2 diabetic patients independent of an aerobic training program and should be considered for the nutritional management of hepatic steatosis in people with type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“POo contains a high proportion of unsaturated fatty acids (54% MUFAs, 10% PUFAs) (Table 1), which have been reported to increase β -oxidation rates (37, 39) and reduce liver fat (40).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Bantle (2008) · doi:10.2337/dc08-s061 · Cited by 1,795
Automatic quantitation of localized in vivo1H spectra with LCModel
Provencher, S. W. (2001) · NMR in Biomedicine · doi:10.1002/nbm.698 · Cited by 1,640
Powell, E. E., Cooksley, G. W. E., Hanson, R., Searle, J., Halliday, J. W., & Powell, L. W. (1990) · Hepatology · doi:10.1002/hep.1840110114 · Cited by 1,473
Lavine, J. E. (2011) · JAMA · doi:10.1001/jama.2011.520 · Cited by 1,108
Johnson, N. A., Sachinwalla, T., Walton, D. W., Smith, K., Armstrong, A., Thompson, M. W., & George, J. (2009) · Hepatology · doi:10.1002/hep.23129 · Cited by 631
Targher, G., Bertolini, L., Poli, F., Rodella, S., Scala, L., Tessari, R., Zenari, L., & Falezza, G. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3541 · Cited by 582
Differential oxidation of individual dietary fatty acids in humans
DeLany, J. P., Windhauser, M. M., Champagne, C. M., & Bray, G. A. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.4.905 · Cited by 560
Hallsworth, K., Fattakhova, G., Hollingsworth, K. G., Thoma, C., Moore, S., Taylor, R., Day, C. P., & Trenell, M. I. (2011) · Gut · doi:10.1136/gut.2011.242073 · Cited by 529
Huang, M. A., Greenson, J. K., Chao, C., Anderson, L., Peterman, D., Jacobson, J. A., Emick, D. M., Lok, A. S.-F., & Conjeevaram, H. S. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41334.x · Cited by 441
Flagged first, then by citations
1 of the 41 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–227 of 227
Bourey, R. E., Kaw, M., Lester, S. G., Ghanem, S. S., & Najjar, S. M. (2014) · CRC Press eBooks · doi:10.1201/b16783-4 · Cited by 1
Oliveira, L. G., Moreno, L. G., Melo, D. D. S., Costa-Pereira, L. V., Carvalho, M. M. D. F., Evangelista-Silva, P. H., Alves, A. M., Magalhães, F. D. C., Dias‐Peixoto, M. F., & Esteves, E. A. (2021) · Vide Leaf, Hyderabad eBooks · doi:10.37247/pab.1.2021.6 · Cited by 1
Stokes, C. S. (2022) · Springer eBooks · doi:10.1007/978-3-662-62484-5_19 · Cited by 1
Mellberg, C. (2014) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
de Barros, C. R. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.6.2012.tde-07112012-103357
DİABETES MELLİTUS'UN TIBBİ BESLENME TEDAVİSİNDE YAĞLI TOHUMLARIN KULLANIMI
Çelik, N., & Akbulut, G. (2013) · DergiPark (Istanbul University)
Maresca, L., Castaldo, L., Vitelli, A., Mancini, M. V., Torella, G., Lucci, R., Albano, G., Forno, D. D., Ferro, M., Altieri, V. M., et al. (2013)
Self-citationNonalcoholic Fatty Liver Disease and Steatohepatitis
McCarthy, E. M., & Rinella, M. E. (2016) · Springer eBooks · doi:10.1007/978-3-319-24687-1_29
Delarue, J., & Lallès, J. P. (2016) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2016.09.002
Pereko, K. K. A., Setorglo, J., Steiner‐Asiedu, M., & Tiweh, J. M. (2018) · InTech eBooks · doi:10.5772/intechopen.71368
Zusammenspiel zweier Volkskrankheiten
Schareck, B. (2018) · Diabetes aktuell · doi:10.1055/a-0612-5193
Hepatic fat: Pathogenic trigger or passenger?
Ryan, M. C., & Zelber‐Sagi, S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.05.016
Weniger Kohlenhydrate in der Therapie des Diabetes?
Bosy‐Westphal, A., & Müller, M. J. (2019) · Diabetes aktuell · doi:10.1055/a-1031-7725
Neamatallah, Z., Alabasi, U. M., & Alfawaz, S. S. (2019) · Endocrinology&Metabolism International Journal · doi:10.15406/emij.2019.07.00253
Alghazeer, R. O. (2016) · HAL
Ampong, I. (2020) · Surrey Research Insight Open Access (The University of Surrey) · doi:10.15126/thesis.00857061
NAFLD and Cardiovascular and Cardiac Disease: Clinical Implications
Scorletti, E., & Byrne, C. D. (2020) · Springer eBooks · doi:10.1007/978-3-319-95828-6_9
Self-Management in Nutrition and Exercise
Clookey, S. L. (2021) · Springer eBooks · doi:10.1007/978-3-030-69736-5_11
Ruolo dei farmaci antidiabete nel trattamento della NAFLD
Mantovani, A. (2021) · il Diabete · doi:10.30682/ildia2102b
Diet in different fat content and cardiometabolic health
Wan, Y. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823914-8.00003-3
Javadi, L., Moradi, S., Amirpoor, M., Majidi, V., & Nikniaz, L. (2023) · Crescent Journal of Medical and Biological Sciences · doi:10.34172/cjmb.2023.4002
Moize, V. L., O’Kane, M. P. M., Pagano, C. S., Andreu, A., Molero, J., & Alonso, L. (2025) · Springer eBooks · doi:10.1007/978-981-96-5099-6_8
Taiwanese consensus statement on the use of diabetes‐specific formula: Scientific evidence
Ch, C., Peng, H.-Y., Lee, C., Wang, C., Ko, Y., Chen, W., Hsu, P.-H., Huang, C., Yang, Y., Yeh, K.-M., et al. (2026) · Journal of Diabetes Investigation · doi:10.1111/jdi.70329
Durval, M. C., Brito, L. F., Fanalli, S. L., Ciconello, F. N., de Oliveira, C. S., Nascimento, L. E., da Silva, B. P. M., & César, A. S. M. (2026) · BMC Genomics · doi:10.1186/s12864-026-13086-y
An antisense oligonucleotide targeting STK25 as a long-acting therapeutic candidate for early MASLD
Dong, A., Li, N., Lang, X., Chen, S., Qin, Y., Wang, Y., Wang, H., Guo, M., Yan, A., Song, K., et al. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.103038 · Cited by 1
Müller, M. J., Heymsfield, S. B., & Bosy‐Westphal, A. (2026) · Obesity Facts · doi:10.1159/ofa/adzag006
Metadata
- Authors
- Bozzetto, L., Prinster, A., Annuzzi, G., Costagliola, L., Mangione, A., Vitelli, A., Mazzarella, R., Longobardo, M., Mancini, M., Vigorito, C., Riccardi, G., & Rivellese, A. A.
- Affiliations
- Federico II University Hospital (IT)
- Institute of Biostructure and Bioimaging (IT)
- University of Naples Federico II (IT)
- Corresponding author
- Rivellese, Angela A.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-06-12
- Volume
- 35
- Issue
- 7
- Pages
- 1429-1435
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3379578
- OpenAlex
- W1965542427
- Cited by
- 227
- References
- 41
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 17 · 2023: 15 · 2022: 20 · 2021: 19 · 2020: 25 · 2019: 22 · 2018: 22 · 2017: 20 · 2016: 17 · 2015: 6 · 2014: 13 · 2013: 11 · 2012: 4
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- FP7 Food, Agriculture and Fisheries, Biotechnology
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes, hepatic steatosis, liver fat, monounsaturated fatty acids, dietary fat composition, isocaloric diet, aerobic exercise training, dietary fiber, low glycemic index diet, metformin
- MeSH terms
- Adult, Aged, Diabetes Mellitus, Type 2, Fats, Fatty Acids, Monounsaturated, Fatty Liver, Female, Humans, Liver, Male, Metformin, Middle Aged, Exercise
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
